Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Antibiotic Treatment of Helicobacter Pylori Reduces Intestinal Colonization Rates With Oxalobacter Formigenes

NCT01300039 is registered in ClinicalTrials.gov with VA New York Harbor Healthcare System as lead sponsor.

NCT NCT01300039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01300039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Antibiotic Treatment of Helicobacter Pylori Reduces Intestinal Colonization Rates With Oxalobacter Formigenes
Lead sponsor
VA New York Harbor Healthcare System
Phase
Observational
Overall status
Completed
Start date
January 31, 2003
Completion date
June 30, 2008
Enrollment
50 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

nephrolithiasis